NVIDIA (NVDA) and Eli Lilly (LLY) announce co-innovation AI lab to reinvent drug discovery in the age of AI

The partnership between NVIDIA and Eli Lilly to establish a co-innovation AI lab represents a significant strategic move, with a planned investment of up to $1 billion in resources over five years.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Former Fed Chair Yellen says "I find it extremely chilling for Fed independence; it seems to me that market should be concerned", via CNBC

Citi YouGov UK long-term CPI expectations at 3.8% (prev. 3.9%); 12-month ahead 3.6% (prev. 3.7%)

NVIDIA (NVDA) and Eli Lilly (LLY) announce co-innovation AI lab to reinvent drug discovery in the age of AI

Iranian diplomats are to be banned from entering the European Parliament in response to the Tehran regime’s brutal crackdown on protesters, Politico reports

Chile's Codelco Chairman says 2026 copper production will reach 1.34mln tonnes (prev. 1.33mln tonnes in 2025)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • The two companies will invest up to USD 1bln in talent, infrastructure and compute over five years to support the new AI co-innovation lab.
Context

This collaboration could enhance Eli Lilly's drug discovery processes while boosting NVIDIA's position in the growing AI and healthcare sectors, potentially influencing investor sentiment in both equities and related industries.

Related headlines

The whole workspace, free to try.

Try it free